1330
[6] Seymour RA, Heasman PA. (1995). Tetracyclines in the management of periodontal diseases. A
review.
Journal of Clinical Periodontology
. 22(1), 22-35.
[7] Bahrami F, Morris DL, Pourgholami MH. (2012). Tetracyclines: drugs with huge therapeutic potential.
Mini Reviews in Medicinal Chemistry
. 12(1), 44-52.
[8] Greenstein G, Tonetti M. (2000). The role of controlled drug delivery for periodontitis. The
Research, Science and Therapy Committee of the American Academy of Periodontology.
Journal of Periodontology
. 71(1), 125-40.
[9] Dodwad D, Vaish S, Mahajan A, Chhokra M. (2012). Local drug delivery in periodontics: a strategic
intervention.
International Journal of Pharmacy and Pharmaceutical Sciences
. 4(4), 30-4.
[10] Kaplish V, Walia MK, Kumar S. (2013). Local drug delivery systems in the treatment of
periodontitis: a review.
Pharmacophore
. 4(2).
[11] Esposito E, Carotta V, Scabbia A, Trombelli L, d'Antona P, et al. (1996). Comparative analysis of
tetracycline-containing dental gels: poloxamer-and monoglyceride-based formulations.
International Journal of Pharmaceutics
. 142(1), 9-23.
[12] Armitage GC, Cullinan MP. (2010). Comparison of the clinical features of chronic and aggressive
periodontitis.
Periodontology 2000
. 53, 12-27.
[13] Eckles TA, Reinhardt RA, Dyer JK, Tussing GJ, Szydlowski WM, et al. (1990). Intracrevicular
application of tetracycline in white petrolatum for the treatment of periodontal disease.
Journal of Clinical Periodontology
. 17(7 Pt 1), 454-62.
[14] Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. (2005). Defining the normal bacterial flora of
the oral cavity.
Journal of Clinical Microbiology
. 43(11), 5721-32.
[15] Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. (2003). Comparison of
real-time PCR and culture for detection of
Porphyromonas gingivalis
in subgingival plaque
samples.
Journal of Clinical Microbiology
. 41(11), 4950-4.
[16] Goodson JM, Tanner A, McArdle S, Dix K, Watanabe SM. (1991). Multicenter evaluation of
tetracycline fiber therapy. III. Microbiological response.
Journal of Periodontal Research
.
26(5), 440-51.
[17] Maze GI, Reinhardt RA, Payne JB, Maze C, Baker RA, et al. (1996). Gingival fluid tetracycline release
from bioerodible gels.
Journal of Clinical Periodontology
. 23(12), 1133-6.
[18] Needleman IG, Gerlach RW, Baker RA, Damani NC, Smith SR, Smales FC. (1998). Retention,
antimicrobial activity, and clinical outcomes following use of a bioerodible tetracycline gel in
moderate-to-deep periodontal pockets.
Journal of Periodontology
. 69(5), 578-83.
[19] Baker PJ, Evans RT, Coburn RA, Genco RJ. (1983). Tetracycline and its derivatives strongly bind to
and are released from the tooth surface in active form.
Journal of Periodontology
. 54(10),
580-5.
[20] Ramberg P, Sekino S, Uzel NG, Socransky S, Lindhe J. (2003). Bacterial colonization during de
novo plaque formation.
Journal of Clinical Periodontology
. 30(11), 990-5.
